Kommentare
Literatur
2006). Comparative cost-effectiveness of policy instruments for reducing the global burden of alcohol, tobacco and illicit drug use. Drug and Alcohol Review, 25, 553 – 565.
(2014). Hilfen zu problematischem Alkoholkonsum – Noch kommen wir zu spät. SUCHT, 60, 107 – 113.
(2013). Modelling the impact of alcohol dependence on mortality burden and the effect of available treatment interventions in the European Union. European Neuropsychopharmacology, 23, 89 – 97.
(2014). The tangible common denominator of substance use disorders: a reply to commentaries to Rehm et al. (2013). Alcohol and Alcoholism, 49 (1), 118 – 122. DOI:10.1093/alcalc/agt171
(2014). Reduzierung alkoholbedingter Mortalität durch Behandlung der Alkoholabhängigkeit. SUCHT, 60, 93 – 105.
(2013). Alcohol use disorders and mortality: a systematic review and meta-analysis. Addiction, 108, 1562 – 1578.
(
Literatur
2005). Acamprosate for the treatment of alcohol dependence. Clinical Therapeutics, 27, 695 – 714. Zugriff am 13.12.2013 unter www.sciencedirect.com/science/article/pii/S0149291805001086
(2000). Internationale Klassifikation psychischer Störungen: ICD-10, Kapitel V (F) klinisch-diagnostische Leitlinien. Weltgesundheitsorganisation. Bern: Huber.
(2012). Neurobiologie der Abhängigkeit. Grundlagen und Konsequenzen für Diagnose und Therapie von Suchterkrankungen (1. Aufl.). Stuttgart: Kohlhammer.
(2013). Trinkmengenreduktion: ein ergänzendes Therapieziel bei Alkoholabhängigen? Psychopharmakotherapie, 20, 193 – 198.
(2011). Brief interventions for heavy alcohol users admitted to general hospital wards. The Cochrane database of systematic reviews, 8: CD005191. DOI: 10.1002/14651858.CD005191.pub3
(2003). AWMF-Behandlungsleitlinien: Akutbehandlung alkoholbezogener Störungen. SUCHT, 49, 147 – 167.
(
Literatur
2013). Who is responsible for the publics health? The role of the alcohol industry in the WHO global strategy to reduce the harmful use of alcohol. Addiction, 108, 2045 – 2047.
(2013). Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries. Lancet, 381, 670 – 679.
(2009). Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet, 373, 2223 – 2233.
(
Literatur
2002). Versorgungsstrukturen von Menschen mit Alkoholproblemen in Deutschland. Eine Analyse aus Public-Health-Perspektive. In K. Mann (Hrsg.), Neue Therapieansätze bei Alkoholproblemen (S. 17 – 45). Lengerich: Pabst.
(
Literatur
2013). A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence. European Neuropsychopharmacology, 23, 1432 – 1442.
(2004). The treatment gap in mental health care. Bulletin of the World Health Organization, 82, 858 – 866.
(2013). Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene. Biological Psychiatry, 73, 706 – 713.
(2008). Results from the 2007 National Survey on Drug Use and Health: National Findings (Office of Applied Studies, NSDUH Series H-34, DHHS Publication No. SMA 08 – 4343). Rockville, MD. Retrieved from www.oas.samhsa.gov/nsduh/2k7nsduh/2k7Results.pdf
(2013). Efficacy of as-needed nalmefene in alcohol-dependent patients with at least a high drinking risk level: results from a subgroup analysis of two randomized controlled 6-month studies. Alcohol and Alcoholism, 48, 570 – 578.
(
Literatur
Literatur
2003). Alcohol: No Ordinary Commodity – Research and Public Policy. New York: Oxford University Press.
(2013). Excess mortality of alcohol-dependent individuals after 14 years and mortality predictors based on treatment participation and severity of alcohol dependence. Alcoholism: Clinical and Experimental Research 37(1), 156 – 163.
(1978). Estimating prevalence from the results of a screening test. American Journal of Epidemiology, 107 (1), 71 – 76.
(2013). Evidenzbasierung der Suchtprävention: Kontra. Suchttherapie, 14, 112 – 113.
(2006). Alkoholpolitik und wissenschaftliche Forschung. Wiener Zeitschrift für Suchtforschung, 29 (3), 5 – 22.
(